Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
How G9a/GLP Inhibition Changes H3K9me2
2026-11-16
BIX 01294 is documented as a selective inhibitor of the H3K9 methyltransferases G9a and GLP. Its reported binding mode offers a mechanistic explanation for reduced H3K9me2 in several cell lines, while the accompanying toxicity finding limits how confidently that cellular readout can be interpreted as target-specific biology.
NHE1 Links Olfr2 Signaling to Atherosclerosis
2026-11-16
A mouse and macrophage study examined whether octanal-associated Olfr2 signaling promotes atherosclerotic changes through the sodium–hydrogen exchanger NHE1. The findings support a model involving altered intracellular pH, calcium- and ROS-associated responses, foam-cell formation, and NLRP3-linked inflammation, while leaving the precise molecular sequence unresolved.
How P2Y12 Blockade Changes Platelet Readouts
2026-11-15
Ticagrelor’s documented action illustrates how receptor-level antagonism can reduce ADP-amplified platelet aggregation, while also showing why an ex vivo aggregation result should not be treated as a complete measure of thrombosis or clinical benefit.
Interpreting Clofoctol’s Documented Activity
2026-11-14
What can be concluded from clofoctol’s documented antibacterial, tissue-distribution, anticancer, and antiviral claims—and where does the evidence remain qualitative?
IRP2, TFEB and Macrophage Antimicrobial Function
2026-11-13
A mouse and macrophage study links myeloid IRP2 to lysosomal acidification, TFEB localization and bacterial clearance during intestinal inflammation. The findings support a mechanistic connection involving HIF2 activity and lactic-acid metabolism, while human biopsy observations provide molecular concordance rather than evidence of treatment efficacy.
H-89 and Wnt-Driven Osteoblast Metabolism
2026-11-13
A mechanistic analysis of how H-89 informs the proposed Ca2+-PKA-GFAT1 pathway linking Wnt signaling to O-GlcNAcylation, glycolysis, and osteoblastogenesis, with emphasis on what the evidence establishes—and what it cannot prove.
Super-Resolution Maps Organelle Proximity
2026-11-12
A methods-focused study shows how Airyscan and structured illumination microscopy, paired with feature-based pixel classification, can improve the structural representation and quantitative analysis of organelles in living cells. The workflow strengthens morphology-based comparisons but does not, by itself, establish molecular tethering or direct nanoscale contact distances.
From RAR Agonism to Cellular Readouts
2026-11-12
How the documented identity of adapalene sodium salt as a synthetic retinoid and RAR agonist supports a mechanistic interpretation—and where that interpretation stops short of product-specific efficacy.
How Umeclidinium Links Receptors to Calcium Flux
2026-11-11
Umeclidinium bromide, also identified as GSK573719A, is documented as a high-affinity antagonist at human muscarinic receptors. Its binding measurements and inhibition of acetylcholine-evoked calcium signals support receptor-level interruption of muscarinic signaling, while remaining distinct from direct evidence of airway dilation or clinical COPD benefit.
How Enzymatic Triglyceride Assays Create Signal
2026-11-11
An enzymatic triglyceride assay converts the glycerol portion of triglycerides into hydrogen peroxide and then into a measurable resorufin signal. Understanding this molecular chain clarifies what fluorescence or absorbance represents, how sample context affects interpretation, and why the documented mechanism should not be mistaken for independent validation of biological or clinical performance.
How Glipizide Links K+ Channels to Insulin Release
2026-11-10
A channel-level explanation of how potassium-channel blockade can connect β-cell electrical activity with insulin secretion, and why the documented neuronal context should not be treated as evidence of the same outcome.
How FSP1 Inhibition Reveals Ferroptosis Defense
2026-11-10
iFSP1 is described as a selective inhibitor of FSP1/AIFM2, a lipid-peroxidation defense pathway that operates separately from the canonical GPX4 system. Its documented cellular effects connect FSP1 inhibition with impaired CoQ10-dependent antioxidant protection, ferroptosis-associated loss of viability, and increased sensitivity to GPX4-directed ferroptosis induction.
Super-Resolution Mapping of Organelle Proximity
2026-11-09
A methods-focused paper evaluates whether Airyscan and structured illumination microscopy, combined with supervised pixel-classification segmentation, can improve morphology-based analysis of organelles and their spatial relationships in living-cell images.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-11-09
A preclinical mouse-model study supports functional crosstalk between CCR7 and Notch1 in mammary cancer stem-like cells, linking chemokine signaling to Notch activation and stemness-associated behavior.
Epiblast Regionalization and Stem-Cell Competence
2026-11-08
A paper-centred interpretation of how anterior–posterior epiblast identity and bivalent chromatin states shape differentiation competence in human pluripotent stem-cell lines, and what chromatin restoration can—and cannot—establish.